Mohan Singh

Mohan Singh

Active Director Director DIN 08103481
DIN 08103481 First appointment Apr 2018 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2018
Shareholding value •••• Premium profile

About Mohan Singh

Data last updated:

Mohan Singh is a Director at Nano Homeopathy Private Limited (since 2018). The company operates in Healthcare. Nano Homeopathy Private Limited reported revenue of ₹1.8 Lakh (FY 2022).

DIN 08103481
Primary Designation Director
Industry Healthcare
First Appointment 05 Apr 2018
Oldest Company Age 8 yrs
Largest company Nano Homeopathy Private Limited · ₹1.8 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nano Homeopathy Private Limited U85320DL2018PTC332000
Director05 Apr 20182018₹1.8 Lakh (FY 2022)Active

Board colleagues of Mohan Singh

Directorship timeline

Open interactive timeline →
Nano Homeopathy Private Limited
Premium access

Shareholding and investment profile for Mohan Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohan Singh

Mohan Singh currently holds 1 directorship: Nano Homeopathy Private Limited (Director, since 05 Apr 2018, revenue ₹1.8 Lakh (FY 2022)).

Mohan Singh was first appointed on 05 Apr 2018 as Director at Nano Homeopathy Private Limited.

The current boards of Mohan Singh's companies include Madhav Shyam (Nano Homeopathy Private Limited), Santosh Kumar Singh (Nano Homeopathy Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available